NG-350A Plus Chemoradiotherapy for Locally Advanced Rectal Cancer

NCT06459869 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced Rectal Cancer (LARC)

Interventions

DRUG: NG-350A IV administration
DRUG: Capecitabine oral administration
RADIATION: Radiotherapy

Sponsor

Akamis Bio